Detection of autoantibodies using chemiluminescence technologies

References

• Plotz C, Singer J. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med 1956;21:888–892
   PubMed Web of Science ®Google Scholar
• Yalow RS, Berson SA. Assay of plasma insulin in human subjects by immunological methods. Nature 1959;184:1648–1649
   PubMed Web of Science ®Google Scholar
• Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971;8:871–874
   PubMedGoogle Scholar
• Van Weemen BK, Schuurs AH. Immunoassay using antigen-enzyme conjugates. FEBS Lett 1971;15:232–236
   PubMed Web of Science ®Google Scholar
• Campbell AK, Patel A. A homogeneous immunoassay for cyclic nucleotides based on chemiluminescence energy transfer. Biochem J 1983;216:185–194
   PubMed Web of Science ®Google Scholar
• Rongen HA, Hoetelmans RM, Bult A, van Bennekom WP. Chemiluminescence and immunoassays. J Pharm Biomed Anal 1994;12:433–462
   PubMed Web of Science ®Google Scholar
• Dodeigne C, Thunus L, Lejeune R. Chemiluminescence as diagnostic tool. A review. Talanta 2000;51:415–439
   PubMed Web of Science ®Google Scholar
• Bentow C, Swart A, Wu J, et al. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens. Clin Chim Acta 2013;424:141–147
   PubMed Web of Science ®Google Scholar
• Mahler M, Parker T, Peebles CL, et al. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol 2012;39:2104–2110
   PubMed Web of Science ®Google Scholar
• Mahler M, Norman GL, Meroni PL, Khamashta M. Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmun Rev 2012;12:313–317
   PubMed Web of Science ®Google Scholar
• Thompson JA, Bau HH. Microfluidic, bead-based assay: theory and experiments. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:228–236
   PubMed Web of Science ®Google Scholar
• Lakos G, Norman GL, Mahler M, et al. Analytical and clinical comparison of two fully automated immunoassay systems for the diagnosis of celiac disease. J Immunol Res 2014;2014:371263
   PubMed Web of Science ®Google Scholar
• Arias-Loste MT, Bonilla G, Moraleja I, et al. Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease. Clin Rev Allergy Immunol 2013;45:109–116
   PubMed Web of Science ®Google Scholar
• Bentow C, Lakos G, Rosenblum R, et al. Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus. Immunol Res 2015; 61:110–116
   PubMed Web of Science ®Google Scholar
• Fitch-Rogalsky C, Steber W, Mahler M, et al. Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies. PLoS One 2014;9:e93812
   PubMed Web of Science ®Google Scholar
• Infantino M, Bentow C, Seaman A, et al. Highlights on novel technologies for the detection of antibodies to Ro60, Ro52, and SS-B. Clin Dev Immunol 2013;2013:978202
   PubMed Web of Science ®Google Scholar
• Mahler M, Satoh M, Hudson M, et al. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests. J Rheumatol 2014;41:1334–1343
   PubMed Web of Science ®Google Scholar
• Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014;2014:315179
   PubMed Web of Science ®Google Scholar
• Mahler M, Dervieux T. Comments on recent advances and recommendations for the assessment of autoantibodies to cellular antigens referred as antinuclear antibodies. Ann Rheum Dis 2014;73:e36
   PubMed Web of Science ®Google Scholar
• Mahler M, Bogdanos DP, Pavlidis P, et al. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease. Clin Chim Acta 2013;424:267–273
   PubMed Web of Science ®Google Scholar
• Mahler M, Gascon C, Patel S, et al. Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay. Arthritis Res Ther 2013;15:R50
   PubMed Web of Science ®Google Scholar
• Miyara M, Albesa R, Charuel JL, et al. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort. Clin Dev Immunol 2013;2013:703759
   PubMed Web of Science ®Google Scholar
• Mondejar R, Gonzalez-Rodriguez C, Toyos-Saenz de Miera FJ, et al. Role of antiphospholipid score and anti-beta2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome. Clin Chim Acta 2014;431:174–178
   PubMed Web of Science ®Google Scholar
• Musset L, Miyara M, Benveniste O, et al. Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies. J Immunol Res 2014;2014:405956
   PubMed Web of Science ®Google Scholar
• Noel N, Andre C, Bengoufa D, et al. Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice. Autoimmun Rev 2013;12:1118–1122
   PubMed Web of Science ®Google Scholar
• Stinton LM, Bentow C, Mahler M, et al. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC). PLoS One 2014;9:e112877
   PubMed Web of Science ®Google Scholar
• Webb T, Lakos G, Swart A, et al. Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies. Clin Chim Acta 2014;437:161–167
   PubMed Web of Science ®Google Scholar
• Yee A, Webb T, Seaman A, et al. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res 2015;61:24–30
   PubMed Web of Science ®Google Scholar
• Mahler M, Radice A, Sinico RA, et al. Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrol Dial Transplant 2012;27:243–252
   PubMed Web of Science ®Google Scholar
• Infantino M, Meacci F, Bentow C, et al. Clinical comparison of QUANTA flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies. J Immunol Res 2015;2015:902821
   PubMed Web of Science ®Google Scholar
• Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136–160
   PubMed Web of Science ®Google Scholar
• Van HF, Persijn L, Decavele AS, Devreese K. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Int J Lab Hematol 2012;34:630–640
   PubMed Web of Science ®Google Scholar
• Noubouossie D, Valsamis J, Corazza F, et al. An automated chemiluminescence immunoassay may detect mostly relevant IgG anticardiolipin antibodies according to revised Sydney criteria. Acta Clin Belg 2012;67:184–189
   PubMed Web of Science ®Google Scholar
• Forastiero R, Papalardo E, Watkins M, et al. Evaluation of different immunoassays for the detection of antiphospholipid antibodies: report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 2014;428:99–105
   PubMed Web of Science ®Google Scholar
• Ciesla M, Wypasek E, Undas A. IgA antiphospholipid antibodies and anti-domain 1 of beta 2 glycoprotein 1 antibodies are associated with livedo reticularis and heart valve disease in antiphospholipid syndrome. Adv Clin Exp Med 2014;23:729–733
   PubMed Web of Science ®Google Scholar
• Pengo V, Ruffatti A, Tonello M, et al. Antiphospholipid syndrome: antibodies to domain 1 of beta2-glycoprotein 1 correctly classify patients at risk. J Thromb Haemost 2015;13:782–787
   PubMed Web of Science ®Google Scholar
• Schulte-Pelkum J, Radice A, Norman GL, et al. Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies. J Immunol Res 2014;2014:185416
   PubMed Web of Science ®Google Scholar
• Mahler M, Radice A, Yang W, et al. Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clin Chim Acta 2012;413:719–726
   PubMed Web of Science ®Google Scholar
• Hirose O, Itabashi M, Takei T, Nitta K. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis. Mod Rheumatol 2015;25:230–234
   PubMed Web of Science ®Google Scholar
• Chan EK, Fritzler MJ, Wiik A, et al. AutoAbSC.Org – autoantibody standardization committee in 2006. Autoimmun Rev 2007;6:577–580
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526–1533
   PubMed Web of Science ®Google Scholar
• Trouw LA, Mahler M. Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis. Autoimmun Rev 2012;12:318–322
   PubMed Web of Science ®Google Scholar
• Fritzler MJ. Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent. Autoimmun Highlight 2012;3:51–58
   PubMedGoogle Scholar
• Mahler M, Fritzler MJ. Anti-dsDNA antibody testing in the clinic: farr or ELISA? Nat Clin Pract Rheumatol 2007;3:72–73
   PubMedGoogle Scholar
• Hanly JG, Su L, Farewell V, Fritzler MJ. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Method 2010;358:75–80
   PubMed Web of Science ®Google Scholar
• Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005;37:360–363
   PubMed Web of Science ®Google Scholar
• Infantino M, Meacci F, Bentow C, et al. Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies. J Immunol Res 2015;2015:902821
   Google Scholar